Follicular Lymphoma Pipeline Review, Industry Study, Research and Clinical trial 2016 – 2020

| December 20, 2016

article image
The Market research comprehensive data on Follicular Lymphoma Market Product Pipeline Review, 2016, is well organized and easily readable. This group is engage in a wide range of other fields and businesses like report generation, R&D, development of innovative drugs and others. It provides an overview of the Follicular Lymphoma Market pharmaceutical research and development focus.The report provides you deep knowledge on the therapeutics under development by Follicular Lymphoma Market, comprehensive analysis gives you total information on stage of development, mechanism of action (MoA), drug target, molecule type and route of administration (RoA). The Follicular Lymphoma report also well understood industry perspective and fulfill industrial requirement by providing descriptive pharmacological action of the therapeutics includes its complete research & development history and the dormant and discontinued projects.

Spotlight

Medpace

A therapeutically focused leader in research-based drug development, Medpace builds strong strategic partnerships with select Sponsors to advance the most efficient and cost-effective path to drug approval. As a full service, global Clinical Research Organization (CRO), Medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input.

OTHER ARTICLES

The Future of Pharma Beyond Blockbusters

Article | March 17, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 17, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

Top Pharmaceutical Firms Urge FDA to Adopt Blockchain for Drug Tracking

Article | March 17, 2020

Leading market participants in the United States pharmaceutical industry, logistics firms, distributors and other stakeholders in the pharma supply chain have come together to publish a report buttressing the need for industry players to adopt blockchain for tracking prescription drugs, following the successful completion of a DLT pilot project with the Food and Drug Administration (FDA), according to reports on February 24, 2020. Though nascent, blockchain technology, the building blocks of Bitcoin (BTC) and other cryptocurrencies are fast gaining ground across various ecosystems, due to its immutability, security, privacy, and other intricate properties. In the latest development, 25 leading manufacturers of pharmaceutical products, logistics partners and other market participants in the pharma supply chain, have published a report that highlights the importance of blockchain technology in drug traceability.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | March 17, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Spotlight

Medpace

A therapeutically focused leader in research-based drug development, Medpace builds strong strategic partnerships with select Sponsors to advance the most efficient and cost-effective path to drug approval. As a full service, global Clinical Research Organization (CRO), Medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input.

Events